Alabama Medicaid agrees to remove sobriety mandate for hepatitis C drugs

Alabama Medicaid reached an agreement with the Justice Department to end a longstanding policy that denied coverage of hepatitis C medication for those who consumed alcohol or drugs within six months of starting treatment or while using the medication.  

Advertisement

The Justice Department alleged that Alabama’s restrictions violated the Americans with Disabilities Act, according to a Dec. 5 news release from the agency. The department said that direct-acting antiviral medications cure hepatitis C in more than 95 percent of cases. It said “abstaining from alcohol or illicit drugs is not medically required for this successful outcome.”

Alabama Medicaid worked cooperatively to modify its policies and will “engage in a robust effort to notify Medicaid recipients and Medicaid providers of these changes, as well as promptly remedy any instances where the prior policy is applied,” according to the release. 

Advertisement

Next Up in Payer

Advertisement

Comments are closed.